Skip to main content

Advertisement

SpringerLink
Log in

Outcome Measures After Sclerotherapy of Venous Malformations: A Systematic Review

  • Review
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Objective

Sclerotherapy has become an important treatment option in the management of vascular malformations. However, little is known about success rate for treatment of venous malformations. This systematic review assesses the available published literature on outcome measures of sclerotherapy for venous malformations.

Data Source

PubMed and EMBASE.

Review Method

A systematic search was conducted, and studies from March 2008 to October 2016 were included. Based on the identified search results, study selection, data extraction, and assessment of study quality were, according to PRISMA, undertaken independently by two reviewers.

Results

One randomized controlled trial and 44 cohort studies were included. The most frequently used measuring methods were subjective measurements, objective measurements, imaging like MRI and ultrasound, and finally patient reported outcome measure survey. Approximately 60% of the studies used more than one measuring method. Outcome measures were pain, swelling, disfigurement, cosmetic complains, patient satisfaction, physical difficulties, volume, diameter, mass, color, shape, size, venous flow, occlusion of venous space, blood pool ratio, and radioisotope uptake.

Conclusions

The published literature over the past 10 years shows no clear method to evaluate the effect of sclerotherapy for venous malformation. We suggest that a standard set of outcome measures should be defined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sierre S, Teplisky D, Lipsich J. Vascular malformations: an update on imaging and management. Arch Argent Pediatr. 2016;114(2):167–76.

    PubMed  Google Scholar 

  2. Gurgacz S, Zamora L, Scott NA. Percutaneous sclerotherapy for vascular malformations: a systematic review. Ann Vasc Surg. 2014;28(5):1335–49.

    Article  PubMed  Google Scholar 

  3. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):1–6.

    Article  Google Scholar 

  4. Sullivan D, Chung KC, Eaves FF, Rohrich RJ. The level of evidence pyramid: indicating levels of evidence in plastic and reconstructive surgery articles. Plast Reconstr Surg. 2011;128(1):311–4.

    Article  PubMed  CAS  Google Scholar 

  5. Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47(3):578–84.

    Article  PubMed  Google Scholar 

  6. Li J, Chen J, Zheng G, Liao G, Fu Z, Li J, Zhang T, Su Y. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region. J Oral Maxillofac Surg. 2010;68(9):2258–66.

    Article  PubMed  Google Scholar 

  7. Dompmartin A, Blaizot X, Theron J, Hammer F, Chene Y, Labbe D, Barrellier MT, Gaillard C, Leroyer R, Chedru V, et al. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations. Eur Radiol. 2011;21(12):2647–56.

    Article  PubMed  Google Scholar 

  8. Spence J, Krings T, TerBrugge KG, Agid R. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck. 2011;33(1):125–30.

    Article  PubMed  Google Scholar 

  9. Jin Y, Lin X, Chen H, Li W, Hu X, Ma G, Zhu L, Sun M, Yang C, Wang W. Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome. J Oral Maxillofac Surg. 2009;67(11):2388–96.

    Article  PubMed  Google Scholar 

  10. Van der Linden E, Otoide-Vree M, Pattynama PM. Percutaneous treatment of peripheral vascular malformations in children: long-term clinical outcome. Cardiovasc Intervent Radiol. 2012;35(2):316–24.

    Article  PubMed  Google Scholar 

  11. Chen Y, Li Y, Zhu Q, Zeng Q, Zhao J, He X, Mei Q. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations. AJR Am J Roentgenol. 2008;190(4):966–71.

    Article  PubMed  Google Scholar 

  12. Lee IH, Kim KH, Jeon P, Byun HS, Kim HJ, Kim ST, Kim YW, Kim DI, Choi JY. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results. Korean J Radiol. 2009;10(3):269–76.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Blaise S, Charavin-Cocuzza M, Riom H, Brix M, Seinturier C, Diamand JM, Gachet G, Carpentier PH. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review. Eur J Vasc Endovasc Surg. 2011;41(3):412–7.

    Article  PubMed  CAS  Google Scholar 

  14. Li L, Feng J, Zeng XQ, Li YH. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: preliminary experience. J Vasc Surg. 2009;49(4):961–7.

    Article  PubMed  Google Scholar 

  15. Gulsen F, Cantasdemir M, Solak S, Gulsen G, Ozluk E, Numan F. Percutaneous sclerotherapy of peripheral venous malformations in pediatric patients. Pediatr Surg Int. 2011;27(12):1283–7.

    Article  PubMed  Google Scholar 

  16. Bai N, Chen YZ, Fu YJ, Wu P, Zhang WN. A clinical study of pingyangmycin sclerotherapy for venous malformation: an evaluation of 281 consecutive patients. J Clin Pharm Ther. 2014;39(5):521–6.

    Article  PubMed  CAS  Google Scholar 

  17. Odeyinde SO, Kangesu L, Badran M. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them. J Plast Reconstr Aesthet Surg. 2013;66(2):215–23.

    Article  PubMed  CAS  Google Scholar 

  18. Ali S, Weiss CR, Sinha A, Eng J, Mitchell SE. The treatment of venous malformations with percutaneous sclerotherapy at a single academic medical center. Phlebology. 2016;31(9):603–9.

    Article  PubMed  Google Scholar 

  19. Guevara CJ, Gonzalez-Araiza G, Kim SK, Sheybani E, Darcy MD. Sclerotherapy of diffuse and infiltrative venous malformations of the hand and distal forearm. Cardiovasc Intervent Radiol. 2016;39(5):705–10.

    Article  PubMed  Google Scholar 

  20. Lamba S, Keshava SKN, Moses V, Surendrababu N, Gupta AK. Ethanol sclerotherapy for treatment of venous malformations of face and neck—a single centre experience. Eur J Plast Surg. 2012;35:345–50.

    Article  Google Scholar 

  21. Chen WL, Huang ZQ, Zhang DM, Chai Q. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin. Head Neck. 2010;32(4):467–72.

    PubMed  Google Scholar 

  22. Kaji N, Kurita M, Ozaki M, Takushima A, Harii K, Narushima M, Wakita S. Experience of sclerotherapy and embolosclerotherapy using ethanolamine oleate for vascular malformations of the head and neck. Scand J Plast Reconstr Surg Hand Surg. 2009;43(3):126–36.

    Article  PubMed  Google Scholar 

  23. Chen H, Lin X, Jin Y, Li W, Ma G, Hu X. Patients with intralesional hemorrhage in venous malformations: diagnosis and embolosclerotherapy. J Vasc Surg. 2009;49(2):429–33 (Discussion 433–424).

    Article  PubMed  Google Scholar 

  24. Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47(6):1292–9.

    Article  PubMed  Google Scholar 

  25. Chen AW, Liu YR, Li K, Zhang K, Wang T, Liu SH. Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck. Br J Oral Maxillofac Surg. 2015;53(9):809–13.

    Article  PubMed  Google Scholar 

  26. Chen WL, Yang ZH, Bai ZB, Wang YY, Huang ZQ, Wang YJ. A pilot study on combination compartmentalisation and sclerotherapy for the treatment of massive venous malformations of the face and neck. J Plast Reconstr Aesthet Surg. 2008;61(12):1486–92.

    Article  PubMed  Google Scholar 

  27. Costa JR, Torriani MA, Hosni ES, D’Avila OP, de Figueiredo PJ. Sclerotherapy for vascular malformations in the oral and maxillofacial region: treatment and follow-up of 66 lesions. J Oral Maxillofac Surg. 2011;69(6):e88–92.

    Article  PubMed  Google Scholar 

  28. Kishi K, Morita N, Terada T, Sato M. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations. Phlebology. 2014;29(5):276–86.

    Article  PubMed  CAS  Google Scholar 

  29. Hoque S, Das BK. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases. Pediatr Surg Int. 2011;27(5):527–31.

    Article  PubMed  Google Scholar 

  30. Schumacher M, Dupuy P, Bartoli JM, Ernemann U, Herbreteau D, Ghienne C, Guibaud L, Loose DA, Mattassi R, Petit P, et al. Treatment of venous malformations: first experience with a new sclerosing agent—a multicenter study. Eur J Radiol. 2011;80(3):e366–72.

    Article  PubMed  Google Scholar 

  31. Das B, Hoque S. Treatment of venous malformations with ethanolamine oleate. Asian J Surg. 2008;31(4):220–4.

    Article  PubMed  Google Scholar 

  32. Orlando JL, Caldas JG, Campos HG, Nishinari K, Wolosker N. Ethanol sclerotherapy of superficial venous malformation: a new procedure. Dermatology. 2010;220(4):376–80.

    Article  PubMed  CAS  Google Scholar 

  33. Orlando JL, Caldas JG, Campos HG, Nishinari K, Krutman M, Wolosker N. Ethanol sclerotherapy of head and neck venous malformations. Einstein. 2014;12(2):181–5.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Liu Y, Liu D, Wang Y, Zhang W, Zhao F. Clinical study of sclerotherapy of maxillofacial venous malformation using absolute ethanol and pingyangmycin. J Oral Maxillofac Surg. 2009;67(1):98–104.

    Article  PubMed  Google Scholar 

  35. Mohan AT, Adams S, Adams K, Hudson DA. Intralesional bleomycin injection in management of low flow vascular malformations in children. J Plast Surg Hand Surg. 2015;49(2):116–20.

    Article  PubMed  Google Scholar 

  36. Alexander MD, McTaggart RA, Choudhri OA, Marcellus ML, Do HM. Percutaneous sclerotherapy with ethanolamine oleate for venous malformations of the head and neck. J Neurointerv Surg. 2014;6(9):695–8.

    Article  PubMed  Google Scholar 

  37. Caty V, Kauffmann C, Dubois J, Mansour A, Giroux MF, Oliva V, Piche N, Therasse E, Soulez G. Clinical validation of semi-automated software for volumetric and dynamic contrast enhancement analysis of soft tissue venous malformations on magnetic resonance imaging examination. Eur Radiol. 2014;24(2):542–51.

    Article  PubMed  Google Scholar 

  38. Li L, Zeng XQ, Li YH. Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations. AJR Am J Roentgenol. 2010;194(5):W439–44.

    Article  PubMed  Google Scholar 

  39. Nakahata K, Uehara S, Zenitani M, Nakamura M, Osuga K, Okuyama H. Patient satisfaction after sclerotherapy of venous malformations in children. Pediatr Int. 2016;58(8):721–5.

    Article  PubMed  CAS  Google Scholar 

  40. Orlando JL, Caldas JG, Campos HG, Nishinari K, Wolosker N. Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia. Clinics. 2010;65(9):837–40.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Delgado J, Bedoya MA, Gaballah M, Low DW, Cahill AM. Percutaneous sclerotherapy of foot venous malformations: evaluation of clinical response. Clin Radiol. 2014;69(9):931–8.

    Article  PubMed  CAS  Google Scholar 

  42. Spence J, Krings T, terBrugge KG, da Costa LB, Agid R. Percutaneous sclerotherapy for facial venous malformations: subjective clinical and objective MR imaging follow-up results. AJNR Am J Neuroradiol. 2010;31(5):955–60.

    Article  PubMed  CAS  Google Scholar 

  43. Yun WS, Kim YW, Lee KB, Kim DI, Park KB, Kim KH, Do YS, Lee BB. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging. J Vasc Surg. 2009;50(3):581–9.

    Article  PubMed  Google Scholar 

  44. Park HS, Do YS, Park KB, Kim KH, Woo SY, Jung SH, Kim DI, Kim YW, Hyun D, Cho SK, et al. Clinical outcome and predictors of treatment response in foam sodium tetradecyl sulfate sclerotherapy of venous malformations. Eur Radiol. 2016;26(5):1301–10.

    Article  PubMed  Google Scholar 

  45. Van der Linden E, Pattynama PMT, Heeres BC, De Jong SC, Hop WCJ, Kroft LJM. Long-term patient satisfaction after percutaneous treatment of peripheral vascular malformations. Radiology. 2009;251(3):926–32.

    Article  PubMed  Google Scholar 

  46. Alexander MD, McTaggart RA, Choudhri OA, Pandit RP, Wu A, Ross M, Do HM. Quantitative volumetric analysis of head and neck venous and lymphatic malformations to assess response to percutaneous sclerotherapy. Acta Radiol. 2016;57(2):205–9.

    Article  PubMed  Google Scholar 

  47. Su L, Fan X, Zheng L, Zheng J. Absolute ethanol sclerotherapy for venous malformations in the face and neck. J Oral Maxillofac Surg. 2010;68(7):1622–7.

    Article  PubMed  Google Scholar 

  48. Andreisek G, Nanz D, Weishaupt D, Pfammatter T. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study. J Vasc Interv Radiol. 2009;20(7):879–87.

    Article  PubMed  Google Scholar 

  49. Furukawa H. Efficacy of percutaneous ethanol sclerotherapy for venous malformation in lower extremities: a retrospective review of 21 cases. Eur J Plast Surg. 2013;36:105–10.

    Article  Google Scholar 

Download references

Acknowledgements

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Plastic and Breast Surgery, Aarhus University Hospital, Nørrebrogade 44, 8000, Aarhus C, Denmark

    Kristina R. Asdahl & Tine Damsgaard

  2. Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark

    Lene Hedelund

  3. Department of Orthopedic Surgery, Aarhus University Hospital, Aarhus, Denmark

    Johnny Keller & Thomas Baad-Hansen

Authors
  1. Kristina R. Asdahl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lene Hedelund
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Johnny Keller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas Baad-Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tine Damsgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kristina R. Asdahl.

Ethics declarations

Conflict of interest

We have no conflicts of interest to disclose.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Does not apply.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asdahl, K.R., Hedelund, L., Keller, J. et al. Outcome Measures After Sclerotherapy of Venous Malformations: A Systematic Review. Cardiovasc Intervent Radiol 41, 1141–1151 (2018). https://doi.org/10.1007/s00270-018-1919-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-018-1919-y

Keywords

Search

Navigation